CROI 2020 Program and Conference Information

Poster Sessions

542 RELATIONSHIPS BETWEENHEPATIC STEATOSIS AND FRAILTY DIFFER BY HIV SEROSTATUS Paula Debroy , Benjamin Barrett, Kristine M. Erlandson, Matthew Budoff, Todd T. Brown, Jennifer C. Price, Wendy Post, Valentina Stosor, Carling Lellock, Gypsyamber D'Souza, Jordan E. Lake NAFLD AND LIVER FIBROSIS PREDICT HIGH CARDIOVASCULAR RISK INHIV-MONOINFECTED PATIENT Giovanni Mazzola, Adriana Cervo , Giovanni Guaraldi, Thomas Krahn, Jovana Milic, Annamaria De Luca, Claudia Gioè, Benedetta Romanin, Marcello Trizzino, Sergio Mazzola, Pietro Colletti, Salvatore Petta, Giada Sebastiani, Antonio Cascio “FIB-4 FIRST”STRATEGY IN A NAFLD PATHWAY ASSESSMENT FOR HIVMONOINFECTED PATIENTS Adriana Cervo , Thomas Krahn, Jovana Milic, Sahar Saeed, Bertrand Lebouché, Marina Klein, Philip Wong, Marc Deschenes, Peter Ghali, Antonio Cascio, Giovanni Mazzola, Giovanni Guaraldi, Giada Sebastiani TRYPTOPHAN CATABOLISM IS ALTERED AMONG PERSONSWITH HIVWHO HAVE STEATOSIS Andreas D. Knudsen , Marco Gelpi, Søren Bjørnskov, Ditte M. Kirkegaard- Klitbo, Anne-Mette Lebech, Henrik Ullum, Klaus F. Kofoed, Øivind Midttun, Per M. Ueland, Jens D. Lundgren, Susanne D. Nielsen IL-18 IS ASSOCIATEDWITHHEPATOSTEATOSIS AND HIGHER LIVER ENZYMES IN PEOPLEWITHHIV Jae H. Sim , Julia B. Sherman, Kathleen V. Fitch, Sara E. Looby, Jake A. Robinson, Michael Lu, Steven K. Grinspoon, Tricia H. Burdo, Janet Lo EASL BIOMARKERS DIFFER IN PREDICTING NAFLD, NASH, AND FIBROSIS INHIV+/- INDIVIDUALS Ricky Hsu , Laurence Brunet, Jennifer S. Fusco, Gregory Fusco Poster P-J02 HCV: FIBROSIS, MORTALITY, AND OTHER LONG-TERM COMPLICATIONS Poster Hall B 2:30 PM - 4:00 PM 548 AN RCT OF RALTEGRAVIR- VERSUS EFAVIRENZ-BASED ART IN HIV-HCV COINFECTION Thuy Le , Chau V. Nguyen, Thao P. Vu, Ly T. Vo, Thanh T. Nguyen, Thu T. Nguyen, Robert Paul, Lishomwa C. Ndhlovu, Dominic Chow, Cecilia M. Shikuma 549 HEPATIC STEATOSIS ASSOCIATEDWITH EXPOSURE TO ELVITEGRAVIR AND RALTEGRAVIR Thomas Benfield, Jens D. Lundgren, Flemming Bendtsen, Susanne D. Nielsen, Ditte M. Kirkegaard-Klitbo 550 BENEFITS OF RILPIVIRINE FOR LIVER FIBROSIS INHIV/HCV COINFECTED SUBJECTS Maria Luisa Montes , Carmen Busca, Antonio Olveira, Luz Martin- Carbonero, Eulalia Valencia, Victoria Moreno, Jose I. Bernardino, Ignacio Pérez-Valero, Rocio Montejano, Rafael Micán, Rosa De Miguel, Jose R. Arribas, Juan González-García 543 544 545 546 547

Poster Sessions • Monday

CROI 2020 78